Aclarion Inc. (Nasdaq: ACON, ACONW), a Broomfield healthcare technology company, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its 24th issued US patent. This new patent expands Aclarion’s proprietary rights to utilize magnetic resonance spectroscopy (MRS) to measure propionic acid (PA) as a biomarker for identifying potential…
Annual Membership Required
You must be a Annual member to access this content.
Already a member? Log in here